Search

Your search keyword '"Newsome AS"' showing total 154 results

Search Constraints

Start Over You searched for: Author "Newsome AS" Remove constraint Author: "Newsome AS" Journal neurology Remove constraint Journal: neurology
154 results on '"Newsome AS"'

Search Results

1. White Matter Disruption in Pediatric Traumatic Brain Injury: Results from ENIGMA Pediatric Moderate to Severe Traumatic Brain Injury.

2. OCARINA I, Phase Ib Study: Dose Selection of Subcutaneous Ocrelizumab in Patients with Multiple Sclerosis (P10-6.003)

Catalog

Books, media, physical & digital resources

4. OCARINA II, Phase III Study: Results of Subcutaneous Ocrelizumab Administration in Patients with Multiple Sclerosis (S31.006)

15. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease

16. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease

17. Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis

23. Unmasking of a Relapsing Encephalomyelitis After SARS-CoV-2 Infection and COVID-19 Vaccination

24. Therapeutic Plasma Exchange in the Management of Stiff Person Syndrome Spectrum Disorders: A Case Series and Review of the Literature

29. White Matter Disruption in Pediatric Traumatic Brain Injury: Results from ENIGMA Pediatric Moderate to Severe Traumatic Brain Injury

30. Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis

35. Early Treatment with Natalizumab Is Associated with Improved Long-Term Cognitive and Physical Performance in Multiple Sclerosis: Results from MS PATHS (4970)

37. Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy

38. Retinal pathology occurs in stiff-person syndrome

42. ENIGMA Military Brain Injury: Altered Subcortical Volume in Chronic TBI Revealed by Mega-Analysis (P2.9-061)

44. A Phase 1b, open-label study to evaluate the safety and tolerability of the putative remyelinating agent, liothyronine, in individuals with multiple sclerosis (S56.003)

49. Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis